Sign In
Buy ICAD
$3.87
+0 (+0%)
At Close: Oct 16, 2025
NASHUA, N.H., April 11, 2024 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global leader in clinically proven AI-powered cancer detection solutions, announced today it will showcase its ProFound Br
NASHUA, N.H. and HALIFAX, Nova Scotia, April 09, 2024 (GLOBE NEWSWIRE) -- iCAD, Inc . (NASDAQ: ICAD), a global leader in clinically proven AI-powered cancer detection solutions, announced a strategic
Study confirms iCAD's Breast Arterial Calcification AI Algorithm successfully detects calcification of breast vessels, an indicator of cardiovascular disease, from mammograms Study confirms iCAD's Bre
iCAD Unveils ProFound Cloud, Enabling Interoperability and Access to Breast AI Solutions at Enterprise Scale
08:00am, Tuesday, 02'nd Apr 2024
ProFound Cloud redefines accessibility to critical insights, empowering radiologists in early breast cancer detection ProFound Cloud redefines accessibility to critical insights, empowering radiologis
Artificial Intelligence, Real Profits: 3 Stocks to Outsmart the Market
02:00pm, Thursday, 14'th Mar 2024
The market is overlooking many stocks that could benefit from the proliferation of AI over the longer term. There are companies using AI to solve real-world problems, and others providing the raw mate
iCAD, Inc. (ICAD) Q4 2023 Earnings Call Transcript
10:59pm, Tuesday, 12'th Mar 2024
iCAD, Inc. (ICAD) Q4 2023 Earnings Call Transcript
iCAD Announces Fiscal Fourth Quarter and Full-Year 2023 Financial Results
04:01pm, Tuesday, 12'th Mar 2024
Annual Recurring Revenue of $8.7 million, an increase of 15% year-over-year Full-Year Operating Cash Flow ($5) million vs. ($12.8) million prior year Year ending cash balance of $21.7M
The Hot List: 3 AI Stocks Worth Buying on Weakness
07:30am, Friday, 01'st Mar 2024
Wall Street has correctly recognized that artificial intelligence (AI) is a game-changer. It enables individuals to use computers more easily than ever before to find the best answers to complex quest
NASHUA, N.H., Feb. 28, 2024 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD) a global leader in clinically proven AI-powered solutions that enable medical providers to accurately and reliably detect canc
iCAD expands Board of Directors with the appointment of Dr. Hedvig Hricak, MD, PhD, (Dr.h.cᵐ)
09:05am, Tuesday, 27'th Feb 2024
Dr. Hricak offers extensive experience in radiology, real-world application of AI-enabled imaging solutions, research, and global healthcare perspectives Dr. Hricak offers extensive experience in radi
iCAD to Report Fourth Quarter and Full Year 2023 Financial Results on March 12, 2024
08:05am, Tuesday, 27'th Feb 2024
NASHUA, N.H., Feb. 27, 2024 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD) a global leader in clinically proven AI-powered solutions that enable medical providers to accurately and reliably detect canc
Wealth Accumulation: 3 Stocks with Multibagger Potential
06:00am, Tuesday, 05'th Dec 2023
While it's never easy to identify multibagger stocks, this may be one of the best times in decades to “swing for the fences” by buying undervalued growth names that are well-positioned to at least
iCAD's AI-powered solutions to Help Accelerate Breast Cancer Detection in New Collaboration with GE Healthcare
08:00am, Tuesday, 28'th Nov 2023
NASHUA, N.H., Nov. 28, 2023 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader in innovative cancer-detection solutions, today announced that key artificial intelligence
iCAD's ProFound AI Can Predict 1-2 Year Risk for Breast Cancer and Reveal Insights for Heart Disease
08:00am, Monday, 27'th Nov 2023
New research presented at Radiological Society of North America annual meeting confirms ability of ProFound Breast Health Suite to predict a woman's one to two-year risk for breast cancer iCAD unveils
Discover Future Growth Stocks: 3 Penny Stocks Poised for Massive Returns
08:12am, Wednesday, 22'nd Nov 2023
Penny stocks are usually small-cap stocks, and small-cap stocks typically tend to perform the best during the early stages of the business cycle when the economy is recovering and growing fairly rapid
